Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07315204) titled 'Viability Assessment Using Flavin Mononucleotide (FMN) Measured in Perfusate and Bile During Normothermic Machine Perfusion' on Dec. 18, 2025.
Study Type: Observational
Primary Sponsor: The Cleveland Clinic
Condition:
Liver Transplant Disorder
Recruitment Status: Recruiting
Date of First Enrollment: December 29, 2025
Target Sample Size: 850
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07315204
Published by HT Digital Content Services with permission from Health Daily Digest....